RxDoctor Payments Data

Kathryn Phillips, PA

Physician Assistant · Federal Way, WANPI 1275936684

Payments from drug & device makers

$1,462in general payments, 2019–2025

Across 50 payments — averaging $29.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$553
  • Bristol Myers Squibb$205
  • Janssen Scientific Affairs, LLC$127
  • Lilly USA, LLC$108
  • Phathom Pharmaceuticals, Inc.$80
  • Takeda Pharmaceuticals U.S.A., Inc.$73
  • plus $316 from 7 others

What the payments were for

  • Food & beverage$1,462100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,462 in reported general payments places this provider in the 85th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$24,081
Medicare patients
207
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VemlidyTenofovir Alafenamide18$23,453
LinzessLinaclotide11$8,712
Mesalamine52$8,041
Omeprazole86$1,779
Pantoprazole Sodium71$905
Esomeprazole Magnesium29$834
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl23$471
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl26$459
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine13$444
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl20$332
Azathioprine15$270
Famotidine52$200
Dicyclomine Hcl18$101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$553$8,71211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Federal Way

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →